Theravance Biopharma Inc (TBPH)

TBPH carries a buy bias supported primarily by a robust ADX that signals a meaningful trend and by medium-term averages that sit below the current price, suggesting constructive underlying trend positioning. Momentum and oscillators are largely neutral, while MACD is flat, and ATR is low, indicating subdued volatility as price action consolidates near its pivot. On-balance volume is negative, which tempers conviction, but the clustering of supportive moving averages across the 50- and 100-period series lends weight to the gentle bullish tilt. Technical takeaway: Buy — trend strength and mid-term moving-average support favor a modest bullish stance.